Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
DEI Network founders: Let’s work together to increase diversity across all cancer centers in America
Conversation with The Cancer LetterHealth Equity

DEI Network founders: Let’s work together to increase diversity across all cancer centers in America

December 03, 2021
Vol.47 No.44
By Matthew Bin Han Ong
What the NCI cancer centers program looked like in 1975
Cancer History ProjectConversation with The Cancer LetterFree

What the NCI cancer centers program looked like in 1975
Previously unpublished “memos for the record” by program’s first leader, John Yarbro, tell all

December 03, 2021
Vol.47 No.44
By Paul Goldberg
In Brief

Richard Fisher steps down from leadership roles at Fox Chase Cancer Center

December 03, 2021
Vol.47 No.44
In Brief

Scott Lippman named vice chancellor, transitioning from UCSD Moores director role

December 03, 2021
Vol.47 No.44
Sharpless: It’s time to confront the current reality of cancer and unravel it
Cancer History ProjectFreeNCI

Sharpless: It’s time to confront the current reality of cancer and unravel it

November 05, 2021
Vol.47 No.41
By Alice Tracey
AACR Cancer Progress Report underscores need for continued investment in cancer research
Capitol Hill

AACR Cancer Progress Report underscores need for continued investment in cancer research

October 15, 2021
Vol.47 No.38
By Alice Tracey
Pancreatic cysts are common and usually benign—except those that turn deadly
Free

Pancreatic cysts are common and usually benign—except those that turn deadly
An NCI trial compares surveillance regimens

October 08, 2021
Vol.47 No.37
By Paul Goldberg
David Weinberg: Only NCI has the capacity to answer public health question on managing pancreatic cysts
Conversation with The Cancer LetterFree

David Weinberg: Only NCI has the capacity to answer public health question on managing pancreatic cysts

October 08, 2021
Vol.47 No.37
By Paul Goldberg
Peter O’Dwyer and Mitch Schnall on the challenges of running screening and prevention trials
Conversation with The Cancer LetterFree

Peter O’Dwyer and Mitch Schnall on the challenges of running screening and prevention trials

October 08, 2021
Vol.47 No.37
By Paul Goldberg
U.S. cancer patients gained 14 million life-years since 1980 because of NCI-funded trials

U.S. cancer patients gained 14 million life-years since 1980 because of NCI-funded trials

October 01, 2021
Vol.47 No.36
By Matthew Bin Han Ong

Posts navigation

Previous1…353637…39Next

Trending Stories

  • Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
  • Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
  • A new diagnostic lens—and a lasting scientific legacy
  • A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
    The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.
  • OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill
  • Is it time to re-assess the practice and practicality of screening colonoscopy?
    Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account